Vertaling van "d'une insuline humaine " (Frans → Nederlands) :

TERMINOLOGIE

produit contenant de l'insuline asparte et de l'insuline aspart protamine
product dat insuline aspart en insuline aspart protamine bevat

entérovirus humain entérovirus non humain 71
humaan enterovirus uitgezonderd humaan enterovirus 71

insuline soluble bovine
oplosbare insuline van rund

insuline isophane bovine
isofane insuline van rund

produit contenant de l'insuline dégludec
product dat insuline degludec bevat

insuline bovine
insuline uit rund

cartouche de stylo à insuline
patroon voor insuline-auto-injector

syndrome auto-immun de l'insuline
insuline-auto-immuunsyndroom

stylo à insuline électronique
elektronische insulinepen

insuline détémir
insuline detemir

IN-CONTEXT TRANSLATIONS

Nombre de Médicaments contre le diabète patients 2008 A10AB01 INSULINE HUMAINE (fast-acting) 27.240 A10AB04 INSULINE LISPRO (fast-acting) 5.583 A10AB05 INSULINE ASPARTE (fast-acting) 29.705 A10AB06 INSULINE GLULISINE (fast-acting) 2.239 A10AC01 INSULINE HUMAINE (intermediate-acting) 27.481 A10AD01 INSULINE HUMAINE (intermediate+fast-acting) 50.278 A10AD05 INSULINE ASPART (intermediate+fast-acting) 2.627 A10AE01 INSULINE HUMAINE (long-acting) 15.565 A10AE04 INSULINE GLARGINE (long-acting) 35.968 A10AE05 INSULINE DETEMIR (long-acting) 8.770 A10A INSULINES ET ANALOGUES Dont ceux qui ne prennent pas d'hypoglycémiant oraux : 129.478 67.473 A10BA02 METFORMINE 341.879 A10BB01 GLIBENCLAMIDE 12.565 A10BB07 GLIPIZIDE 3.795 A10BB08 GLIQUIDONE 39.952 A10BB09 GLICLAZIDE 99.680 A10BB12 GLIMEPIRIDE 24.522 A10BD02 METFORMINE ET DERIVES DE LA SULFONYLUREE 17.373 A10BD03 METFORMINE ET ROSIGLITAZONE 769 A10BG02 ROSIGLITAZONE 13.684 A10BG03 PIOGLITAZONE 1.841 A10BH01 SITAGLIPTINE 6.249 A10BX02 REPAGLINIDE 50.192 A10BX04 EXENATIDE 2.461 A10B HYPOGLYCEMIANTS ORAUX Dont ceux qui ne prennent pas d'insulines et analogues : 441.869 379.864
A10AB01 HUMANE INSULINE (fast-acting) 27.240 A10AB04 INSULINE LISPRO (fast-acting) 5.583 A10AB05 INSULINE ASPART (fast-acting) 29.705 A10AB06 INSULINE GLULISINE (fast-acting) 2.239 A10AC01 HUMANE INSULINE (intermediate-acting) 27.481 A10AD01 HUMANE INSULINE (intermediate+fast-acting) 50.278 A10AD04 INSULINE LISPRO 2.627 A10AD05 INSULINE ASPART (intermediate+fast-acting) 15.565 A10AE04 INSULINE GLARGINE (long-acting) 35.968 A10AE05 INSULINE DETEMIR (long-acting) 8.770 A10A INSULINES EN ANALOGEN 129.478 Aantal hiervan dat geen hypoglykemiërende middelen gebruikt 67.473 A10BA02 METFORMINE 341.879 A10BB01 GLIBENCLAMIDE 12.565 A10BB07 GLIPIZIDE 3.795 A10BB08 GLIQUIDON 39.952 A10BB09 GLICLAZIDE 99.680 A10BB12 GLIMEPIRIDE 24.522 A10BD02 METFORMINE MET SULFONYLUREUMDERIVATEN 17.373 A10BD03 METFORMINE MET ROSIGLITAZON 769 A10BG02 ROSIGLITAZON 13.684 A10BG03 PIOGLITAZON 1.841 A10BH01 SITAGLIPTINE 6.249 A10BX02 REPAGLINIDE 50.192 A10BX04 EXENATIDE 2.461 A10B HYPOGLYKEMIERENDE MIDDELEN MET UITZONDERING VAN INSULINES 441.869 Aantal hiervan dat geen insulines en analogen gebruikt 379.864

A10AB01 INSULINE HUMAINE (fast-acting) 30.110 A10AB04 INSULINE LISPRO (fast-acting) 5.078 A10AB05 INSULINE ASPARTE (fast-acting) 16.638 A10AC01 INSULINE HUMAINE (intermediate-acting) 32.744 A10AD01 INSULINE HUMAINE (intermediate+fast-acting) 56.796 A10AD05 INSULINE ASPART (intermediate+fast-acting) 5.979 A10AE01 INSULINE HUMAINE (long-acting) 788 A10AE04 INSULINE GLARGINE (long-acting) 24.161 A10AE05 INSULINE DETEMIR (long-acting) 1.841 A10A INSULINES ET ANALOGUES 110.007 Dont ceux qui ne prennent pas d'hypoglycémiant oraux : 60.190 A10BA02 METFORMINE 251.410 A10BB01 GLIBENCLAMIDE 18.492 A10BB07 GLIPIZIDE 5.995 A10BB08 GLIQUIDONE 39.557 A10BB09 GLICLAZIDE 90.936 A10BB12 GLIMEPIRIDE 27.961 A10BD02 METFORMINE ET DERIVES DE LA SULFONYLUREE 16.042 A10BD03 METFORMINE ET ROSIGLITAZONE 289 A10BG02 ROSIGLITAZONE 12.871 A10BG03 PIOGLITAZONE 1.800 A10BX02 REPAGLINIDE 38.748 A10B HYPOGLYCEMIANTS ORAUX 357.775 Dont ceux qui ne prennent pas d'insulines et analogues : 307.958
Aantal Geneesmiddelen tegen diabetes patiënten 2005 A10AB01 HUMANE INSULINE (fast-acting) 30.110 A10AB04 INSULINE LISPRO (fast-acting) 5.078 A10AB05 INSULINE ASPART (fast-acting) 16.638 A10AC01 HUMANE INSULINE (intermediate-acting) 32.744 A10AD01 HUMANE INSULINE (intermediate+fast-acting) 56.796 A10AD05 INSULINE ASPART (intermediate+fast-acting) 5.979 A10AE01 HUMANE INSULINE (long-acting) 788 A10AE04 INSULINE GLARGINE (long-acting) 24.161 A10AE05 INSULINE DETEMIR (long-acting) 1.841 A10A INSULINES EN ANALOGEN 110.007 aantal hiervan dat geen hypoglykemiërende middelen gebruikt 60.190 A10BA02 METFORMINE 251.410 A10BB01 GLIBENCLAMIDE 18.492 A10BB07 GLIPIZIDE 5.995 A10BB08 GLIQUIDON 39.557 A10BB09 GLICLAZIDE 90.936 A10BB12 GLIMEPIRIDE 27.961 A10BD02 METFORMINE MET SULFONYLUREUMDERIVATEN 16.042 A10BD03 METFORMINE MET ROSIGLITAZON 289 A10BG02 ROSIGLITAZON 12.871 A10BG03 PIOGLITAZON 1.800 A10BX02 REPAGLINIDE 38.748 A10B HYPOGLYKEMIERENDE MIDDELEN MET UITZONDERING VAN INSULINES 357.775 Aantal hiervan dat geen insulines en analogen gebruikt 307.958

Médicaments contre le diabète Nombre de patients 2007 A10AB01 INSULINE HUMAINE (fast-acting) 27.972 A10AB04 INSULINE LISPRO (fast-acting) 5.083 A10AB05 INSULINE ASPARTE (fast-acting) 24.718 A10AB06 INSULINE GLULISINE (fast-acting) 997 A10AC01 INSULINE HUMAINE (intermediate-acting) 28.656 A10AD01 INSULINE HUMAINE (intermediate+fast-acting) 53.714 A10AD05 INSULINE ASPART (intermediate+fast-acting) 10.655 A10AE01 INSULINE HUMAINE (long-acting) 122 A10AE04 INSULINE GLARGINE (long-acting) 30.567 A10AE05 INSULINE DETEMIR (long-acting) 7.577 A10A INSULINES ET ANALOGUES 120.352 Dont ceux qui ne prennent pas d'antidiabétiques oraux : 62.933 A10BA02 METFORMINE 295.576 A10BB01 GLIBENCLAMIDE 13.827 A10BB07 GLIPIZIDE 4.303 A10BB08 GLIQUIDONE 39.384 A10BB09 GLICLAZIDE 93.905 A10BB12 GLIMEPIRIDE 24.927 A10BD02 METFORMINE ET DERIVES DE LA SULFONYLUREE 17.041 A10BD03 METFORMINE ET ROSIGLITAZONE 717 A10BG02 ROSIGLITAZONE 15.014 A10BG03 PIOGLITAZONE 1.902 A10BX02 REPAGLINIDE 45.903 A10B ANTIDIABETIQUES ORAUX 397.270 Dont ceux qui ne prennent pas d'insulines et analogues : 339.851
Aantal Geneesmiddelen tegen diabetes patiënten 2007 A10AB01 HUMANE INSULINE (fast-acting) 27.972 A10AB04 INSULINE LISPRO (fast-acting) 5.083 A10AB05 INSULINE ASPART (fast-acting) 24.718 A10AB06 INSULINE GLULISINE (fast-acting) 997 A10AC01 HUMANE INSULINE (intermediate-acting) 28.656 A10AD01 HUMANE INSULINE (intermediate+fast-acting) 53.714 A10AD05 INSULINE ASPART (intermediate+fast-acting) 10.655 A10AE01 HUMANE INSULINE (long-acting) 122 A10AE04 INSULINE GLARGINE (long-acting) 30.567 A10AE05 INSULINE DETEMIR (long-acting) 7.577 A10A INSULINES EN ANALOGEN 120.352 aantal hiervan dat geen orale antidiabetica gebruikt 62.933 A10BA02 METFORMINE 295.576 A10BB01 GLIBENCLAMIDE 13.827 A10BB07 GLIPIZIDE 4.303 A10BB08 GLIQUIDON 39.384 A10BB09 GLICLAZIDE 93.905 A10BB12 GLIMEPIRIDE 24.927 A10BD02 METFORMINE MET SULFONYLUREUMDERIVATEN 17.041 A10BD03 METFORMINE MET ROSIGLITAZON 717 A10BG02 ROSIGLITAZON 15.014 A10BG03 PIOGLITAZON 1.902 A10BX02 REPAGLINIDE 45.903 A10B ORALE ANTIDIABETICA MET UITZONDERING VAN INSULINES 397.270 Aantal hiervan dat geen insulines en analogen gebruikt 339.851

A10AB01 INSULINE HUMAINE (fast-acting) 28.839 A10AB04 INSULINE LISPRO (fast-acting) 4.984 A10AB05 INSULINE ASPARTE (fast-acting) 20.762 A10AC01 INSULINE HUMAINE (intermediate-acting) 29.453 A10AD01 INSULINE HUMAINE (intermediate+fast-acting) 55.183 A10AD05 INSULINE ASPART (intermediate+fast-acting) 7.733 A10AE01 INSULINE HUMAINE (long-acting) 577 A10AE04 INSULINE GLARGINE (long-acting) 27.011 A10AE05 INSULINE DETEMIR (long-acting) 6.166 A10A INSULINES ET ANALOGUES Dont ceux qui ne prennent pas d'hypoglycémiant oraux : 114.589 61.393 A10BA02 METFORMINE 270.080 A10BB01 GLIBENCLAMIDE 15.814 A10BB07 GLIPIZIDE 5.013 A10BB08 GLIQUIDONE 39.358 A10BB09 GLICLAZIDE 91.791 A10BB12 GLIMEPIRIDE 26.516 A10BD02 METFORMINE ET DERIVES DE LA SULFONYLUREE 17.367 A10BD03 METFORMINE ET ROSIGLITAZONE 498 A10BG02 ROSIGLITAZONE 14.168 A10BG03 PIOGLITAZONE 1.816 A10BX02 REPAGLINIDE 41.132 A10B HYPOGLYCEMIANTS ORAUX 375.137
Aantal Geneesmiddelen tegen diabetes patiënten 2006 A10AB01 HUMANE INSULINE (fast-acting) 28.839 A10AB04 INSULINE LISPRO (fast-acting) 4.984 A10AB05 INSULINE ASPART (fast-acting) 20.762 A10AC01 HUMANE INSULINE (intermediate-acting) 29.453 A10AD01 HUMANE INSULINE (intermediate+fast-acting) 55.183 A10AD05 INSULINE ASPART (intermediate+fast-acting) 7.733 A10AE01 HUMANE INSULINE (long-acting) 577 A10AE04 INSULINE GLARGINE (long-acting) 27.011 A10AE05 INSULINE DETEMIR (long-acting) 6.166 A10A INSULINES EN ANALOGEN aantal hiervan dat geen hypoglykemiërende middelen gebruikt 114.589 61.393 A10BA02 METFORMINE 270.080 A10BB01 GLIBENCLAMIDE 15.814 A10BB07 GLIPIZIDE 5.013 A10BB08 GLIQUIDON 39.358 A10BB09 GLICLAZIDE 91.791 A10BB12 GLIMEPIRIDE 26.516 A10BD02 METFORMINE MET SULFONYLUREUMDERIVATEN 17.367 A10BD03 METFORMINE MET ROSIGLITAZON 498 A10BG02 ROSIGLITAZON 14.168 A10BG03 PIOGLITAZON 1.816 A10BX02 REPAGLINIDE 41.132 A10B HYPOGLYKEMIERENDE MIDDELEN MET UITZONDERING VAN INSULINES 375.137

1 A10AB A10AB01 INSULINE HUMAINE 120 1,6% 118,7 A10AB05 INSULINE ASPARTE 119 2,4% 109,0 A10AB04 INSULINE LISPRO 40 2,3% 36,3 2 L02BG L02BG03 ANASTROZOLE 112 1,6% 24,9 L02BG04 LETROZOLE 101 2,9% 22,7 L02BG06 EXEMESTANE 37 2,1% 8,3 3 A10AE A10AE04 INSULINE GLARGINE 224 2,4% 125,5 A10AE05 INSULINE DETEMIR 9 4,5% 5,1 A10AE01 INSULINE HUMAINE 1 0,6% 0,7 4 J05AF J05AF30 ASSOCIATIONS 76 0,8% 4,2 J05AF05 LAMIVUDINE 35 0,9% 5,1 J05AF04 STAVUDINE 35 3,6% 4,5 J05AF06 ABACAVIR 27 1,4% 2,9 J05AF02 DIDANOSINE 22 2,0% 3,2 J05AF01 ZIDOVUDINE 5 1,6% 0,5 5 B02BD B02BD09 NONACOG ALFA 194 11,1% 0,2 6 H03AA H03AA01 LEVOTHYROXINE SODIQUE 189 2,7% 1.935,5 H03AA03 ASSOCIATIONS DE LEVOTHYROXINE ET DE LIOTHYRONI 5 2,8% 37,2 7 L01XX L01XX28 IMATINIB 180 1,2% 1,6 L01XX05 HYDROXYCARBAMIDE 4 0,6% 2,6 L01XX14 TRETINOINE 1 8,6% 0,1 L01XX11 ESTRAMUSTINE 0 0,0% 0,1 8 C10AA C10AA05 ATORVASTATINE 78 0,1% 117,0 C10AA01 SIMVASTATINE 52 0,1% 148,1 C10AA03 PRAVASTATINE 31 0,1% 55,2 C10AA07 ROSUVASTATINE 15 0,1% 19,2 C10AA04 FLUVASTATINE 3 0,1% 6,1 9 H01CB H01CB03 LANREOTIDE 83 2,1% 2,3 H01CB02 OCTREOTIDE 72 0,7% 1,9 10 A10AD A10AD01 INSULINE HUMAINE 101 0,5% 99,8 A10AD05 INSULINE ASPART 46 2,1% 42,3 11 H01AC H01AC01 SOMATROPINE 108 0,8% 5,2 12 M05BA M05BA06 ACIDE IBANDRONIQUE 47 6,9% 3,9 M05BA04 ACIDE ALENDRONIQUE 45 0,1% 38,4 M05BA07 ACIDE RISEDRONIQUE 7 0,1% 5,7 M05BA02 ACIDE CLODRONIQUE 2 0,2% 0,2 13 L02BA L02BA01 TAMOXIFENE 95 1,6% 133,3 L02BA02 TOREMIFENE 0 0,6% 0,2 14 J05AE J05AE06 LOPINAVIR 48 1,4% 3,3 J05AE03 RITONAVIR 11 2,1% 1,0 J05AE07 FOSAMPRENAVIR 9 1,0% 0,8 J05AE04 NELFINAVIR 8 1,1% 0,7 J05AE02 INDINAVIR 5 1,9% 0,5 J05AE01 SAQUINAVIR 2 0,6% 0,2 J05AE05 AMPRENAVIR 1 1,1% 0,1 15 A02BC A02BC01 OMEPRAZOLE 34 0,1% 49,5 A02BC02 PANTOPRAZOLE 14 0,0% 7,2 A02BC04 RABEPRAZOLE 12 0,1% 5,9 A02BC05 ESOMEPRAZOLE 10 0,0% 5,7 A02BC03 LANSOPRAZOLE 7 0,1% 3,9 16 A10AC A10AC01 INSULINE HUMAINE 65 1,0% 63,7 17 C09AA C09AA04 PERINDOPRIL 21 0,1% 27,3 C09AA03 LISINOPRIL 19 0,1% 75,4 C09AA01 CAPTOPRIL 8 0,1% 21,7 C ...
1 A10AB A10AB01 HUMANE INSULINE 120 1,6% 118,7 A10AB05 INSULINE ASPART 119 2,4% 109,0 A10AB04 INSULINE LISPRO 40 2,3% 36,3 2 L02BG L02BG03 ANASTROZOL 112 1,6% 24,9 L02BG04 LETROZOL 101 2,9% 22,7 L02BG06 EXEMESTAAN 37 2,1% 8,3 3 A10AE A10AE04 INSULINE GLARGINE 224 2,4% 125,5 A10AE05 INSULINE DETEMIR 9 4,5% 5,1 A10AE01 HUMANE INSULINE 1 0,6% 0,7 4 J05AF J05AF30 COMBINATIEPREPARATEN 76 0,8% 4,2 J05AF05 LAMIVUDINE 35 0,9% 5,1 J05AF04 STAVUDINE 35 3,6% 4,5 J05AF06 ABACAVIR 27 1,4% 2,9 J05AF02 DIDANOSINE 22 2,0% 3,2 J05AF01 ZIDOVUDINE 5 1,6% 0,5 5 B02BD B02BD09 NONACOG ALFA 194 11,1% 0,2 6 H03AA H03AA01 LEVOTHYROXINE 189 2,7% 1.935,5 H03AA03 LEVOTHYROXINE MET LIOTHYRONINE 5 2,8% 37,2 7 L01XX L01XX28 IMATINIB 180 1,2% 1,6 L01XX05 HYDROXYCARBAMIDE 4 0,6% 2,6 L01XX14 TRETINOINE 1 8,6% 0,1 L01XX11 ESTRAMUSTINE 0 0,0% 0,1 8 C10AA C10AA05 ATORVASTATINE 78 0,1% 117,0 C10AA01 SIMVASTATINE 52 0,1% 148,1 C10AA03 PRAVASTATINE 31 0,1% 55,2 C10AA07 ROSUVASTATINE 15 0,1% 19,2 C10AA04 FLUVASTATINE 3 0,1% 6,1 9 H01CB H01CB03 LANREOTIDE 83 2,1% 2,3 H01CB02 OCTREOTIDE 72 0,7% 1,9 10 A10AD A10AD01 HUMANE INSULINE 101 0,5% 99,8 A10AD05 INSULINE ASPART 46 2,1% 42,3 11 H01AC H01AC01 SOMATROPINE 108 0,8% 5,2 12 M05BA M05BA06 IBANDRONINEZUUR 47 6,9% 3,9 M05BA04 ALENDRONINEZUUR 45 0,1% 38,4 M05BA07 RISEDRONINEZUUR 7 0,1% 5,7 M05BA02 CLODRONINEZUUR 2 0,2% 0,2 13 L02BA L02BA01 TAMOXIFEN 95 1,6% 133,3 L02BA02 TOREMIFEN 0 0,6% 0,2 14 J05AE J05AE06 LOPINAVIR 48 1,4% 3,3 J05AE03 RITONAVIR 11 2,1% 1,0 J05AE07 FOSAMPRENAVIR 9 1,0% 0,8 J05AE04 NELFINAVIR 8 1,1% 0,7 J05AE02 INDINAVIR 5 1,9% 0,5 J05AE01 SAQUINAVIR 2 0,6% 0,2 J05AE05 AMPRENAVIR 1 1,1% 0,1 15 A02BC A02BC01 OMEPRAZOL 34 0,1% 49,5 A02BC02 PANTOPRAZOL 14 0,0% 7,2 A02BC04 RABEPRAZOL 12 0,1% 5,9 A02BC05 ESOMEPRAZOL 10 0,0% 5,7 A02BC03 LANSOPRAZOL 7 0,1% 3,9 16 A10AC A10AC01 HUMANE INSULINE 65 1,0% 63,7 17 C09AA C09AA04 PERINDOPRIL 21 0,1% 27,3 C09AA03 LISINOPRIL 19 0,1% 75,4 C09AA01 CAPTOPRIL 8 0,1% 21,7 C09AA05 RAMIPRIL 8 0,1% 32,3 C09AA06 QUINAP ...

Nombre de Médicaments contre le diabète patients 2009 A10AB01 INSULINE HUMAINE (fast-acting) 25.472 A10AB04 INSULINE LISPRO (fast-acting) 5.805 A10AB05 INSULINE ASPARTE (fast-acting) 32.502 A10AB06 INSULINE GLULISINE (fast-acting) 3.957 A10AC01 INSULINE HUMAINE (intermediate-acting) 25.714 A10AD01 INSULINE HUMAINE (intermediate+fast-acting) 43.558 A10AD04 INSULINE LISPRO (intermediate+fast-acting) 3.082 A10AD05 INSULINE ASPARTE (intermediate+fast-acting) 23.041 A10AE04 INSULINE GLARGINE (long-acting) 39.609 A10AE05 INSULINE DETEMIR (long-acting) 9.324 A10A INSULINES ET ANALOGUES Dont ceux qui ne prennent pas d'hypoglycémiant oraux : 132.855 68.954 A10BA02 METFORMINE 371.639 A10BB01 GLIBENCLAMIDE 10.814 A10BB07 GLIPIZIDE 3.174 A10BB08 GLIQUIDONE 38.586 A10BB09 GLICLAZIDE 102.103 A10BB12 GLIMEPIRIDE 22.804 A10BD02 METFORMINE ET DERIVES DE LA SULFONYLUREE 16.231 A10BD03 METFORMINE ET ROSIGLITAZONE 755 A10BD08 METFORMINE ET VILDAGLIPTINE 327 A10BG02 ROSIGLITAZONE 10.971 A10BG03 PIOGLITAZONE 1.534 A10BH01 SITAGLIPTINE 10.689 A10BH02 VILDAGLIPTINE 3.244 A10BX02 REPAGLINIDE 49.667 A10BX04 EXENATIDE 4.646 A10B HYPOGLYCEMIANTS ORAUX Dont ceux qui ne prennent pas d'insulines et analogues : 465.497 401.596
Aantal Geneesmiddelen tegen diabetes patiënten 2009 A10AB01 HUMANE INSULINE (fast-acting) 25.472 A10AB04 INSULINE LISPRO (fast-acting) 5.805 A10AB05 INSULINE ASPART (fast-acting) 32.502 A10AB06 INSULINE GLULISINE (fast-acting) 3.957 A10AC01 HUMANE INSULINE (intermediate-acting) 25.714 A10AD01 HUMANE INSULINE (intermediate+fast-acting) 43.558 A10AD04 INSULINE LISPRO (fast-acting) 3.082 A10AD05 INSULINE ASPART (intermediate+fast-acting) 23.041 A10AE04 INSULINE GLARGINE (long-acting) 39.609 A10AE05 INSULINE DETEMIR (long-acting) 9.324 A10A INSULINES EN ANALOGEN aantal hiervan dat geen hypoglykemiërende middelen gebruikt 132.855 68.954 A10BA02 METFORMINE 371.639 A10BB01 GLIBENCLAMIDE 10.814 A10BB07 GLIPIZIDE 3.174 A10BB08 GLIQUIDON 38.586 A10BB09 GLICLAZIDE 102.103 A10BB12 GLIMEPIRIDE 22.804 A10BD02 METFORMINE MET SULFONYLUREUMDERIVATEN 16.231 A10BD03 METFORMINE MET ROSIGLITAZON 755 A10BD08 METFORMINE EN VILDAGLIPTINE 327 A10BG02 ROSIGLITAZON 10.971 A10BG03 PIOGLITAZON 1.534 A10BH01 SITAGLIPTINE 10.689 A10BH02 VILDAGLIPTINE 3.244 A10BX02 REPAGLINIDE 49.667 A10BX04 EXENATIDE 4.646 A10B HYPOGLYKEMIERENDE MIDDELEN MET UITZONDERING VAN INSULINES Aantal hiervan dat geen insulines en analogen gebruikt 465.497 401.596

A10 MEDICAMENTS ANTIDIABETIQUES 560.207 100,0% 100,0% Dont ceux qui prennent des insulines et analogues et des hypoglicémiants oraux: 66.105 11,8% 11,8% A10A INSULINES ET ANALOGUES 136.753 100,0% 24,4% Dont ceux qui ne prennent pas d'hypoglycémiant oraux : 70.648 51,7% 12,6% A10AB01 INSULINE HUMAINE (fast-acting) 24.100 17,6% 4,3% A10AB04 INSULINE LISPRO (fast-acting) 7.151 5,2% 1,3% A10AB05 INSULINE ASPARTE (fast-acting) 35.726 26,1% 6,4% A10AB06 INSULINE GLULISINE (fast-acting) 5.714 4,2% 1,0% A10AC01 INSULINE HUMAINE (intermediate-acting) 24.496 17,9% 4,4% A10AD01 INSULINE HUMAINE (intermediate+fast-acting) 38.129 27,9% 6,8% A10AD04 INSULINE LISPRO (intermediate+fast-acting) 3.249 2,4% 0,6% A10AD05 INSULINE ASPARTE (intermediate+fast-acting) 25.219 18,4% 4,5% A10AE04 INSULINE GLARGINE (long-acting) 44.146 32,3% 7,9% A10AE05 INSULINE DETEMIR (long-acting) 10.043 7,3% 1,8%
A10AB01 HUMANE INSULINE (fast-acting) 24.100 17,6% 4,3% A10AB04 INSULINE LISPRO (fast-acting) 7.151 5,2% 1,3% A10AB05 INSULINE ASPART (fast-acting) 35.726 26,1% 6,4% A10AB06 INSULINE GLULISINE (fast-acting) 5.714 4,2% 1,0% A10AC01 HUMANE INSULINE (intermediate-acting) 24.496 17,9% 4,4% A10AD01 HUMANE INSULINE (intermediate+fast-acting) 38.129 27,9% 6,8% A10AD04 INSULINE LISPRO (fast-acting) 3.249 2,4% 0,6% A10AD05 INSULINE ASPART (intermediate+fast-acting) 25.219 18,4% 4,5% A10AE04 INSULINE GLARGINE (long-acting) 44.146 32,3% 7,9% A10AE05 INSULINE DETEMIR (long-acting) 10.043 7,3% 1,8%

On utilise généralement une injection d’une insuline « basale », c.-à-d. une insuline à durée d’action intermédiaire (insuline humaine isophane) ou un analogue insulinique à longue durée d’action (insuline détémir ou insuline glargine).
In het algemeen gebruikt men een injectie van een “basale” insuline, d.w.z. een insuline met intermediaire werkingsduur (humane insuline-isofaan) of een insulineanaloog met lange werkingsduur (insuline detemir of insuline glargine).

L’insuline glulisine est obtenue par remplacement dans l’insuline humaine des acides aminés asparagine et lysine respectivement par la lysine et l’acide glutamique.
Insuline glulisine wordt bekomen door vervanging in het humaan insuline van de aminozuren asparagine en lysine door respectievelijk lysine en glutaminezuur.

Ce sont des insulines humaines obtenues par la technologie recombinante.
Dit zijn humane insulines, resultaat van recombinant-technologie.